Yi-Ju Chen

Prof. Yi-Ju Chen

Department of Biological Science and Technology, National Yang Ming Chiao Tung University, Hsinchu, Taiwan
orcid
Assistant Professor

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Cell
Verified
Journal Article
Open access
Yi-Ju ChenYi-Ju Chen
Yi-Ju Chen
TRTheodoros I. Roumeliotis
Theodoros I. Roumeliotis
YCYa-Hsuan Chang
Ya-Hsuan Chang
CCChing-Tai Chen
Ching-Tai Chen
CHChia-Li Han
Chia-Li Han
Yu-Ju ChenYu-Ju Chen
Yu-Ju Chen
Lung cancer in East Asia is characterized by a high percentage of never-smokers, early onset and predominant EGFR mutations. To illuminate the molecular phenotype of this demographically distinct disease, we performed a deep comprehensive proteogenomic study on a prospectively collected cohort in Taiwan, representing early stage, predominantly female, non-smoking lung adenocarcinoma. Integrated genomic, proteomic, and phosphoproteomic analysis delineated the demographically distinct molecular attributes and hallmarks of tumor progression. Mutational signature analysis revealed age- and gender-related mutagenesis mechanisms, characterized by high prevalence of APOBEC mutational signature in younger females and over-representation of environmental carcinogen-like mutational signatures in older females. A proteomics-informed classification distinguished the clinical characteristics of early stage patients with EGFR mutations. Furthermore, integrated protein network analysis revealed the cellular remodeling underpinning clinical trajectories and nominated candidate biomarkers for patient stratification and therapeutic intervention. This multi-omic molecular architecture may help develop strategies for management of early stage never-smoker lung adenocarcinoma.

26 November 2012 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
CLCheng-Tsung Lu
Cheng-Tsung Lu
KHKai-Yao Huang
Kai-Yao Huang
MSMin-Gang Su
Min-Gang Su
TLTzong-Yi Lee
Tzong-Yi Lee
NBNeil Arvin Bretaña
Neil Arvin Bretaña
HHHsien-Da Huang
Hsien-Da Huang
Protein modification is an extremely important post-translational regulation that adjusts the physical and chemical properties, conformation, stability and activity of a protein; thus altering protein function. Due to the high throughput of mass spectrometry (MS)-based methods in identifying site-specific post-translational modifications (PTMs), dbPTM (http://dbPTM.mbc.nctu.edu.tw/) is updated to integrate experimental PTMs obtained from public resources as well as manually curated MS/MS peptides associated with PTMs from research articles. Version 3.0 of dbPTM aims to be an informative resource for investigating the substrate specificity of PTM sites and functional association of PTMs between substrates and their interacting proteins. In order to investigate the substrate specificity for modification sites, a newly developed statistical method has been applied to identify the significant substrate motifs for each type of PTMs containing sufficient experimental data. According to the data statistics in dbPTM, >60% of PTM sites are located in the functional domains of proteins. It is known that most PTMs can create binding sites for specific protein-interaction domains that work together for cellular function. Thus, this update integrates protein–protein interaction and domain–domain interaction to determine the functional association of PTM sites located in protein-interacting domains. Additionally, the information of structural topologies on transmembrane (TM) proteins is integrated in dbPTM in order to delineate the structural correlation between the reported PTM sites and TM topologies. To facilitate the investigation of PTMs on TM proteins, the PTM substrate sites and the structural topology are graphically represented. Also, literature information related to PTMs, orthologous conservations and substrate motifs of PTMs are also provided in the resource. Finally, this version features an improved web interface to facilitate convenient access to the resource.

9 December 2016 in Nature Communications
Verified
Journal Article
Open access
HWHan-Tsang Wu
Han-Tsang Wu
YKYi-Chih Kuo
Yi-Chih Kuo
JHJung-Jyh Hung
Jung-Jyh Hung
CHChi-Hung Huang
Chi-Hung Huang
WCWei-Yi Chen
Wei-Yi Chen
KWKou-Juey Wu
Kou-Juey Wu
Intratumoural hypoxia induces HIF-1α and promotes tumour progression, metastasis and treatment resistance. HIF-1α stability is regulated by VHL-E3 ligase-mediated ubiquitin-dependent degradation; however, the hypoxia-regulated deubiquitinase that stabilizes HIF-1α has not been identified. Here we report that HAUSP (USP7) deubiquitinase deubiquitinates HIF-1α to increase its stability, induce epithelial-mesenchymal transition and promote metastasis. Hypoxia induces K63-linked polyubiquitinated HAUSP at lysine 443 to enhance its functions. Knockdown of HAUSP decreases acetylation of histone 3 lysine 56 (H3K56Ac). K63-polyubiquitinated HAUSP interacts with a ubiquitin receptor CBP to specifically mediate H3K56 acetylation. ChIP-seq analysis of HAUSP and HIF-1α binding reveals two motifs responsive to hypoxia. HectH9 is the E3 ligase for HAUSP and a prognostic marker together with HIF-1α. This report demonstrates that hypoxia-induced K63-polyubiquitinated HAUSP deubiquitinates HIF-1α and causes CBP-mediated H3K56 acetylation on HIF-1α target gene promoters to promote EMT/metastasis, further defining HAUSP as a therapeutic target in hypoxia-induced tumour progression.

1 June 2019 in Cell Metabolism
Verified
Journal Article
Closed access
CHChun-Mei Hu
Chun-Mei Hu
STSui-Chih Tien
Sui-Chih Tien
PHPing-Kun Hsieh
Ping-Kun Hsieh
YJYung-Ming Jeng
Yung-Ming Jeng
MCMing-Chu Chang
Ming-Chu Chang
WLWen-Hwa Lee
Wen-Hwa Lee

1 January 2014 in Database: The Journal of Biological Databases and Curation
Verified
Journal Article
Open access
PDF file
KHKai-Yao Huang
Kai-Yao Huang
HWHsin-Yi Wu
Hsin-Yi Wu
Yi-Ju ChenYi-Ju Chen
Yi-Ju Chen
CLCheng-Tsung Lu
Cheng-Tsung Lu
MSMin-Gang Su
Min-Gang Su
Yu-Ju ChenYu-Ju Chen
Yu-Ju Chen
Protein phosphorylation catalyzed by kinases plays crucial roles in regulating a variety of intracellular processes. Owing to an increasing number of in vivo phosphorylation sites that have been identified by mass spectrometry (MS)-based proteomics, the RegPhos, available online at http://csb.cse.yzu.edu.tw/RegPhos2/, was developed to explore protein phosphorylation networks in human. In this update, we not only enhance the data content in human but also investigate kinase–substrate phosphorylation networks in mouse and rat. The experimentally validated phosphorylation sites as well as their catalytic kinases were extracted from public resources, and MS/MS phosphopeptides were manually curated from research articles. RegPhos 2.0 aims to provide a more comprehensive view of intracellular signaling networks by integrating the information of metabolic pathways and protein–protein interactions. A case study shows that analyzing the phosphoproteome profile of time-dependent cell activation obtained from Liquid chromatography-mass spectrometry (LC-MS/MS) analysis, the RegPhos deciphered not only the consistent scheme in B cell receptor (BCR) signaling pathway but also novel regulatory molecules that may involve in it. With an attempt to help users efficiently identify the candidate biomarkers in cancers, 30 microarray experiments, including 39 cancerous versus normal cells, were analyzed for detecting cancer-specific expressed genes coding for kinases and their substrates. Furthermore, this update features an improved web interface to facilitate convenient access to the exploration of phosphorylation networks for a group of genes/proteins. Database URL: http://csb.cse.yzu.edu.tw/RegPhos2/

22 September 2017 in Journal of Proteome Research
Verified
Journal Article
Closed access
LCLanyi Chang
Lanyi Chang
Yi-Ju ChenYi-Ju Chen
Yi-Ju Chen
CFChan-Yo Fan
Chan-Yo Fan
CTChin-Ju Tang
Chin-Ju Tang
PLPenk-Yeir Low
Penk-Yeir Low
TATakashi Angata
Takashi Angata